Status:

COMPLETED

Targeted Small Airways Therapy in Persistent Asthma

Lead Sponsor:

University of Dundee

Collaborating Sponsors:

Teva Pharmaceuticals USA

Conditions:

Asthma

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The mainstay of asthma treatment is with inhaled steroids (commonly called a 'preventer') to keep the symptoms of asthma under control. Increasing strengths of steroid inhaler may be required in order...

Detailed Description

A single centre, open-label, single subject study over a 12-24 week period. Invited participants will receive a written 'Participant Information Sheet' (PIS) detailing the requirements of the trial an...

Eligibility Criteria

Inclusion

  • Male and female volunteers aged 18-65, with persistent asthma
  • Asthma Control Questionnaire score \>1.0 (at end of run-in)
  • FEV1 \>60% predicted
  • R5\>130% predicted and R5-R20\>0.03kPa/L/s
  • Ability to perform spirometry, impulse oscillometry, bronchial challenge and all domiciliary measurements
  • Ability to give informed consent
  • Asthmatic patients receiving treatment at Step 2, 3, or 4 of British Thoracic Society asthma guidelines
  • Ability to withhold long-acting beta-agonists for the duration of the study

Exclusion

  • Patients already receiving extra-fine particle inhaled corticosteroids (Qvar, Fostair, Alvesco)
  • Pregnancy or lactation
  • Known or suspected sensitivity to the Investigational Medicinal Product
  • Inability to comply with protocol
  • Any clinically significant medical conditions that may either endanger the health or safety of the participant, or jeopardise the protocol
  • An asthma exacerbation requiring systemic steroid therapy or lower respiratory tract infection requiring antibiotics within 3 months prior to study commencement
  • Participation in previous trial within 30 days

Key Trial Info

Start Date :

October 28 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 25 2018

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT01894048

Start Date

October 28 2013

End Date

June 25 2018

Last Update

September 9 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brian Lipworth

Dundee, United Kingdom, DD1 3AU